Peter Sguigna News Today

Scientists are investigating whether an oral drug sprinkled with gold nanoparticles could one day treat neurodegenerative diseases like Parkinson's and multiple sclerosis.

"We are cautiously optimistic that we will be able to prevent or even reverse some neurological disabilities with this strategy," researchers said.

The results of phase two clinical studies showed that giving people with Parkinson’s disease and multiple sclerosis (MS) a daily dose of gold nanocrystals dissolved in water led to big improvements. The medication targets an energy imbalance that occurs in the brain, and prior research on animals and humans has shown its potential to mitigate …

“We are cautiously optimistic,” said one investigator.

Phase two clinical trials at UT Southwestern Medical Center revealed that a suspension of gold nanocrystals taken daily by patients with multiple sclerosis (MS) and Parkinson’s disease (PD) significantly reversed deficits in metabolites linked to energy activity in the brain, resulting in functional improvements.

Results from phase two clinical trials at UT Southwestern Medical Center showed that a suspension of gold nanocrystals taken daily by patients with multiple scl